These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 6434542)

  • 1. Species-specific irreversible inhibition of Neisseria gonorrhoeae dihydrofolate reductase by a substituted 2,4-diamino-5-benzylpyrimidine.
    Tansik RL; Averett DR; Roth B; Paterson SJ; Stone D; Baccanari DP
    J Biol Chem; 1984 Oct; 259(19):12299-305. PubMed ID: 6434542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization and amino acid sequence of Neisseria gonorrhoeae dihydrofolate reductase.
    Baccanari DP; Tansik RL; Paterson SJ; Stone D
    J Biol Chem; 1984 Oct; 259(19):12291-8. PubMed ID: 6434541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kinetics of methotrexate binding to dihydrofolate reductase from Neisseria gonorrhoeae.
    Baccanari DP; Tansik RL
    Biochem Pharmacol; 1984 Jul; 33(13):2101-7. PubMed ID: 6430300
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dihydrofolate reductase from Neisseria sp.
    Averett DR; Roth B; Burchall JJ; Baccanari DP
    Antimicrob Agents Chemother; 1979 Mar; 15(3):428-35. PubMed ID: 111611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Affinity labeling of dihydrofolate reductase with an antifolate glyoxal.
    Johanson RA; Henkin J
    J Biol Chem; 1985 Feb; 260(3):1465-74. PubMed ID: 3881433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 2,4-Diamino-5-benzylpyrimidines as antibacterial agents. 7. Analysis of the effect of 3,5-dialkyl substituent size and shape on binding to four different dihydrofolate reductase enzymes.
    Roth B; Rauckman BS; Ferone R; Baccanari DP; Champness JN; Hyde RM
    J Med Chem; 1987 Feb; 30(2):348-56. PubMed ID: 3100802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of chicken liver dihydrofolate reductase by 5-(substituted benzyl)-2,4-diaminopyrimidines. A quantitative structure-activity relationship and graphics analysis.
    Selassie CD; Fang ZX; Li RL; Hansch C; Klein T; Langridge R; Kaufman BT
    J Med Chem; 1986 May; 29(5):621-6. PubMed ID: 3701780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the inhibition of Escherichia coli and Lactobacillus casei dihydrofolate reductase by 2,4-diamino-5-(substituted-benzyl)pyrimidines: quantitative structure-activity relationships, X-ray crystallography, and computer graphics in structure-activity analysis.
    Hansch C; Li R; Blaney JM; Langridge R
    J Med Chem; 1982 Jul; 25(7):777-84. PubMed ID: 6809941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Site-directed mutagenesis of mouse dihydrofolate reductase. Mutants with increased resistance to methotrexate and trimethoprim.
    Thillet J; Absil J; Stone SR; Pictet R
    J Biol Chem; 1988 Sep; 263(25):12500-8. PubMed ID: 3045118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pyrrolo[2,3-d]pyrimidines and pyrido[2,3-d]pyrimidines as conformationally restricted analogues of the antibacterial agent trimethoprim.
    Kuyper LF; Garvey JM; Baccanari DP; Champness JN; Stammers DK; Beddell CR
    Bioorg Med Chem; 1996 Apr; 4(4):593-602. PubMed ID: 8735847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Receptor-based design of dihydrofolate reductase inhibitors: comparison of crystallographically determined enzyme binding with enzyme affinity in a series of carboxy-substituted trimethoprim analogues.
    Kuyper LF; Roth B; Baccanari DP; Ferone R; Beddell CR; Champness JN; Stammers DK; Dann JG; Norrington FE; Baker DJ
    J Med Chem; 1985 Mar; 28(3):303-11. PubMed ID: 3973902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of Pneumocystis carinii, Toxoplasma gondii, and Mycobacterium avium dihydrofolate reductases by 2,4-diamino-5-[2-methoxy-5-(omega-carboxyalkyloxy)benzyl]pyrimidines: marked improvement in potency relative to trimethoprim and species selectivity relative to piritrexim.
    Rosowsky A; Forsch RA; Queener SF
    J Med Chem; 2002 Jan; 45(1):233-41. PubMed ID: 11754594
    [TBL] [Abstract][Full Text] [Related]  

  • 13. On the structure selectivity problem in drug design. A comparative study of benzylpyrimidine inhibition of vertebrate and bacterial dihydrofolate reductase via molecular graphics and quantitative structure-activity relationships.
    Selassie CD; Fang ZX; Li RL; Hansch C; Debnath G; Klein TE; Langridge R; Kaufman BT
    J Med Chem; 1989 Aug; 32(8):1895-905. PubMed ID: 2502631
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Refined crystal structures of Escherichia coli and chicken liver dihydrofolate reductase containing bound trimethoprim.
    Matthews DA; Bolin JT; Burridge JM; Filman DJ; Volz KW; Kaufman BT; Beddell CR; Champness JN; Stammers DK; Kraut J
    J Biol Chem; 1985 Jan; 260(1):381-91. PubMed ID: 3880742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Receptor-based design of dihydrofolate reductase inhibitors: comparison of crystallographically determined enzyme binding with enzyme affinity in a series of carboxy-substituted trimethoprim analogues.
    Kuyper LF; Roth B; Baccanari DP; Ferone R; Beddell CR; Champness JN; Stammers DK; Dann JG; Norrington FE; Baker DJ; Goodford PJ
    J Med Chem; 1982 Oct; 25(10):1120-2. PubMed ID: 6754932
    [No Abstract]   [Full Text] [Related]  

  • 16. On the optimization of hydrophobic and hydrophilic substituent interactions of 2,4-diamino-5-(substituted-benzyl)pyrimidines with dihydrofolate reductase.
    Selassie CD; Li RL; Poe M; Hansch C
    J Med Chem; 1991 Jan; 34(1):46-54. PubMed ID: 1899453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative structure-activity relationships of antimalarial and dihydrofolate reductase inhibition by quinazolines and 5-substituted benzyl-2,4-diaminopyrimidines.
    Hansch C; Fukunaga JY; Jow PY
    J Med Chem; 1977 Jan; 20(1):96-102. PubMed ID: 319234
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Basis of selectivity of antibacterial diaminopyrimidines.
    Baccanari DP; Kuyper LF
    J Chemother; 1993 Dec; 5(6):393-9. PubMed ID: 8195830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 2,4-Diamino-5-benzylpyrimidines as antibacterial agents. 8. The 3,4,5-triethyl isostere of trimethoprim. A study of specificity.
    Roth B; Aig E
    J Med Chem; 1987 Nov; 30(11):1998-2004. PubMed ID: 3312605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New 2,4-diamino-5-(2',5'-substituted benzyl)pyrimidines as potential drugs against opportunistic infections of AIDS and other immune disorders. Synthesis and species-dependent antifolate activity.
    Rosowsky A; Forsch RA; Sibley CH; Inderlied CB; Queener SF
    J Med Chem; 2004 Mar; 47(6):1475-86. PubMed ID: 14998335
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.